Quantitative Protein Testing in CSSDs at KACSDN 2026
Terragene reinforced its global presence at the 2026 Annual General Meeting and Spring Conference organized by KACSDN in Seoul, presenting its approach to quantitative protein testing in CSSDs through evidence-based solutions.
On Friday, March 20th, our Head of Product Specialists and Clinical Educator for Europe and APAC, Antonela Sdrigotti, delivered the lecture “From Assumption to Evidence – Quantitative Protein Testing in CSSDs” to a full room, demonstrating how healthcare facilities can move from subjective assessments to measurable, data-driven cleaning validation, improving safety and process reliability.
Terragene team at KACSDN 2026, Seoul — presenting quantitative protein testing solutions for CSSDs
From assumption to quantitative evidence
Transitioning from visual inspection to quantitative protein testing in CSSDs represents a critical evolution in sterilization workflows.
The presentation highlighted how objective measurement enables healthcare professionals to reduce uncertainty, standardize cleaning validation, and ensure consistent compliance with infection control protocols.
Pro1 Micro: Precision in protein quantification
Pro1 Micro was introduced as a high-sensitivity solution designed for quantitative protein detection on surfaces, enabling accurate measurement of residual contamination after cleaning.
This technology supports CSSDs in validating hygiene processes, particularly in complex and hard-to-access areas, delivering reliable and reproducible data.
PCD: Strengthening sterilization validation
PCD solutions play a key role in validating sterilization processes by simulating worst-case conditions.
Alongside quantitative protein testing in CSSDs, they contribute to a comprehensive approach to process control, ensuring both cleaning and sterilization stages meet the highest standards of safety and performance.
Explore how PCD solutions enhance sterilization validation: